Burning mouth syndrome is a continuous burning sensation of the mucosa of the mouth which typically involves the tongue, but not until the extension to the lips and oral mucosa. Classically, burning mouth syndrome is accompanied by gustatory disturbances like dysgeusia, parageusia and subjective xerostomia. The pathophysiology is considered as psychogenic illness but however, a neuropathic mechanism for burning mouth syndrome is currently favored.
Burning mouth syndrome is fairly common worldwide and affects up to 5 per 100,000 individuals. People with BMS are more likely to be middle aged or elderly, and females are three to seven times more likely to have BMS than males. Some report a female to male ratio of as much as 33 to 1. BMS is reported in about 10-40% of women seeking medical treatment for menopausal symptoms, and BMS occurs in about 14% of postmenopausal women. Males and younger individuals of both sexes are sometimes affected.
Primary treatment can be given with Clonazepam, Topiramate, Olanzapine, Nortriptyline, Doxepin, Hormone replacement therapy, etc. Treatment for secondary treatment includes Adjustment of levothyroxine dosing, oral nystatin, Avoidance of allergens, B vitamin supplementation, and Chewing sorbitol-containing gum to stimulate saliva.